Literature DB >> 10782784

High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT.

T Sasajima1, H Kinouchi, N Tomura, J Watarai, K Mizoi.   

Abstract

We studied a case of olfactory neuroblastoma by noting 123I-metaiodobenzylguanidine (MIBG) uptake revealed by single-photon emission CT (SPECT). MR imaging revealed an enhancing tumor extending from the left nasal cavity to the bilateral anterior frontal cranial fossae. SPECT revealed high 123I-MIBG uptake in the enhancing tumor. SPECT-revealed 123I-MIBG uptake appears to be clinically useful for distinguishing olfactory neuroblastomas from other tumors, especially suprasellar meningiomas.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10782784      PMCID： PMC7976631     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  19 in total

Review 1.  The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience.

Authors:  R S Polin; J P Sheehan; A G Chenelle; E Munoz; J Larner; C D Phillips; R W Cantrell; E R Laws; S A Newman; P A Levine; J A Jane
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

2.  Somatostatin receptor imaging of olfactory neuroblastoma.

Authors:  H A Ramsay; K J Kairemo; A P Jekunen
Journal:  J Laryngol Otol       Date:  1996-12       Impact factor: 1.469

3.  Specificity of radioiodinated MIBG for neural crest tumors in childhood.

Authors:  A Leung; B Shapiro; R Hattner; E Kim; J de Kraker; N Ghazzar; O Hartmann; C A Hoefnagel; D A Jamadar; R Kloos; P Lizotte; J Lumbroso; V Rufini; B L Shulkin; J C Sisson; A Thein; L Troncone
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

4.  Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging.

Authors:  M N Gaze; I M Huxham; R J Mairs; A Barrett
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

Review 5.  Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas.

Authors:  K Lamszus; W Meyerhof; M Westphal
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

7.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.

Authors:  J C Sisson; D M Wieland; P Sherman; T J Mangner; M C Tobes; S Jacques
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

8.  Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.

Authors:  J Buck; G Bruchelt; R Girgert; J Treuner; D Niethammer
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

9.  Neural crest tumors: I-123 MIBG imaging in children.

Authors:  H J Paltiel; M J Gelfand; A H Elgazzar; L C Washburn; R E Harris; P R Masters; G J Golsch
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

10.  MRI of esthesioneuroblastoma.

Authors:  C P Derdeyn; C J Moran; F J Wippold; D P Chason; M B Koby; F Rodriguez
Journal:  J Comput Assist Tomogr       Date:  1994 Jan-Feb       Impact factor: 1.826
View more
  2 in total

1.  Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine.

Authors:  Yuichiro Naitoh; Toshio Sasajima; Hiroyuki Kinouchi; Shigeki Mikawa; Kazuo Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

2.  123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.

Authors:  Toshio Sasajima; Hiroyuki Kinouchi; Yuichiro Naitoh; Noriaki Tomura; Jiro Watarai; Kazuo Mizoi
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.